Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 2,194 | 1,874 | 2,519 | 2,188 | 3,174 |
| Operating Income | -2,194 | -1,874 | -2,519 | -2,188 | -3,174 |
| Other Income | 0 | 0 | 0 | 3 | 26 |
| Pre-tax Income | -2,194 | -1,874 | -2,519 | -2,185 | -3,147 |
| Income Tax | N/A | N/A | N/A | N/A | 7 |
| Net Income Continuous | -2,194 | -1,874 | -2,519 | -2,185 | -3,155 |
| Net Income | $-2,194 | $-1,874 | $-2,519 | $-2,185 | $-3,155 |
| EPS Basic Total Ops | 0.86 | -10.81 | -11.64 | -14.65 | -30.16 |
| EPS Basic Continuous Ops | 6.01 | -5.98 | -11.65 | -14.59 | -30.22 |
| EPS Diluted Total Ops | 0.86 | -10.81 | -11.64 | -14.65 | -30.16 |
| EPS Diluted Continuous Ops | 6.01 | -5.98 | -11.65 | -14.59 | -30.22 |
| EPS Diluted Before Non-Recurring Items | N/A | -10.81 | -11.65 | -14.65 | N/A |
| EBITDA(a) | $-2,154 | $-1,834 | $-2,479 | $-2,107 | $-3,091 |